Concepedia

Andressa S. Laino

AS

Statistics

Publications

12

Citations

864

H-Index

12

Active since

2018

Affiliations

NYU Langone Health(Current)

University of Colorado Denver

Dana-Farber Cancer Institute

Massachusetts General Hospital

University of Colorado Anschutz Medical Campus

Andressa S. Laino is an author at NYU Langone Health specializing in cancer immunotherapy, oncology, and immunotherapy.

ORCID

Publications per year

2018–2024

12

Publications

12

Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition

Andressa S. Laino, David Woods, Melinda Vassallo et al. · Journal for ImmunoTherapy of Cancer · 2020 · 248 citations · Full text

, , +17

T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study

Justin F. Gainor, Manish R. Patel, Jeffrey S. Weber et al. · Cancer Discovery · 2024 · 100 citations

, , +17

C reactive protein impairs adaptive immunity in immune cells of patients with melanoma

Tatsuya Yoshida, Junya Ichikawa, Iulia Giuroiu et al. · Journal for ImmunoTherapy of Cancer · 2020 · 96 citations · Full text

, , +17

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

Andressa S. Laino, Brian C. Betts, Anandharaman Veerapathran et al. · Journal for ImmunoTherapy of Cancer · 2019 · 78 citations · Full text

, , +17

A phase I study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23, and IL-36γ, for intratumoral (iTu) injection alone and in combination with durvalumab.

Manish R. Patel, Todd M. Bauer, Antonio Jimeno et al. · Journal of Clinical Oncology · 2020 · 69 citations

, , +16

1–5 of 12